• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR MITRACLIP SYSTEM STEERABLE GUIDE CATHETER; VALVE REPAIR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR MITRACLIP SYSTEM STEERABLE GUIDE CATHETER; VALVE REPAIR Back to Search Results
Catalog Number UNK SGC01
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cardiac Arrest (1762); High Blood Pressure/ Hypertension (1908); Perforation (2001)
Event Date 11/27/2016
Event Type  Injury  
Manufacturer Narrative
Date of event: date estimated.The udi number is not known as the part and lot number were not provided.The device will not be returned for evaluation.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.Literature: haemodynamic and functional consequences of the iatrogenic atrial septal defect following mitraclip therapy.
 
Event Description
This is being filed to report the atrial septal defect (asd) requiring intervention for treatment and cardiac arrest.It was reported via literature that this was a mitraclip procedure to treat functional mitral regurgitation (mr).The mitraclip was successfully implanted.Following withdrawal of the steerable guide catheter (sgc), the systolic pulmonary pressure increased, right-sided chamber enlargement was observed and a left-to-right shunt was detected, eventually leading to cardiorespiratory arrest.The issue was resolved through percutaneous closure with either an amplatzer or figulla occluder.No additional information was provided.Details are listed in the article: "haemodynamic and functional consequences of the iatrogenic atrial septal defect following mitraclip therapy".
 
Manufacturer Narrative
D4: the udi# is unknown because the part and lot numbers were not provided.The device was not returned for analysis and a review of the lot history record could not be performed as the lot information regarding the complaint devices was not provided.Based on the information reviewed, the reported perforation appears to be due to procedural condition.Hypertension and subsequent cardiac arrest is a cascading effect of the perforation.Perforation, hypertension, and cardiac arrest are listed in the mitraclip instructions for use (ifu) as known possible complications associated with mitraclip procedures.The reported unexpected medical intervention is a result of case-specific circumstance.There is no indication of a product issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP SYSTEM STEERABLE GUIDE CATHETER
Type of Device
VALVE REPAIR
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key11724614
MDR Text Key247277738
Report Number2024168-2021-03511
Device Sequence Number1
Product Code DRA
Combination Product (y/n)N
PMA/PMN Number
K112239
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Type of Report Initial,Followup
Report Date 06/07/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/26/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK SGC01
Was Device Available for Evaluation? No
Date Manufacturer Received05/26/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
-
-